Venture Capital

Updated:

Biogen Idec New Ventures

Biogen was established in 1978 and is headquartered in Massachusetts, US. Biogen discovers, develops, manufactures, and markets biological products for serious...

Biogen Idec New Ventures logo

Biogen Idec New Ventures

Biogen was established in 1978 and is headquartered in Massachusetts, US. Biogen discovers, develops, manufactures, and markets biological products for serious diseases, focusing on neurological disorders. It works with advocacy and patient organizations serving their communities.

General information

Firm type

Venture Capital

Year founded

1978

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Cambridge

Corporate office

225 Binney Street, Cambridge, MA 02142, United States

Additional offices

Baar, Switzerland · Research Triangle Park, NC, United States

Principals

Chelsea Johnson

Head of New Ventures

Sector focus

BiotechnologyHealthcare

Frequently asked questions

Who runs investment decisions at Biogen Idec New Ventures?

Chelsea Johnson serves as Head of New Ventures. She previously worked at Atlas Venture.

Does Biogen Idec New Ventures participate in fund commitments or only direct deals?

The unit holds both direct positions in operating companies and a limited partner stake in the Dementia Discovery Fund.

What investment stages does Biogen Idec New Ventures typically target?

Activity centers on early-stage seed and startup rounds as well as expansion and late-stage opportunities.

Which sectors does Biogen Idec New Ventures focus on?

Investments concentrate in biotechnology companies addressing neurological disorders and immunology.

Where does Biogen Idec New Ventures maintain geographic exposure?

Portfolio companies are located in the United States, Germany, and Switzerland.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Cambridge Venture Capital profiles